Grail inc.GRAL.US Overview

US StockHealthcare

(No presentation for GRAL)

Overview AI Analysis AI Earnings Summary Financials Financial Forecast Stock Sentimental Institutions TradingView Chart

GRAL Overall Performance

GRAL AI Analysis & Strategy

GRAL Recent Performance

0.81%

Grail inc.

0.81%

Avg of Sector

-1.14%

S&P500

GRAL PowerScanner

GRAL Key Information

GRAL Valuation Metrics

GRAL Earnings Table

GRAL Profile

GRAIL, Inc., a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. It is also developing minimal residual disease and other post-diagnostic tests. The company was incorporated in 2015 and is based in Menlo Park, California. GRAIL, Inc. operates as a former subsidiary of Illumina, Inc.